Oculogica, a leader in concussion diagnosis, is proud to announce that its Founder and Scientific Advisor, Dr. Uzma Samadani, has been appointed to the Permanent Council of The Global Alliance for Surgical, Obstetric, Trauma and Anaesthesia Care (The G4 Alliance) as the representative from the ThinkFirst Foundation. The G4 Alliance is committed to advocating for […]
G4 Alliance appoints Dr. Samadani to Permanent Council Read More »
This webinar featured Dr. Avindra Nath, Clinical Director at Translational Neuroscience Center at the National Institute of Neurological Disorders and Stroke (NIH), Dr. Uzma Samadani, neurosurgeon, and Dr. Alice Perlowski, cardiologist. Click here to watch.
Oculogica hosts Webinar: Long COVID and effects of brain Read More »
Minneapolis Clinic of Neurology, one of the largest neurology clinics in the nation, has recently made the decision to offer Oculogica Inc.’s EyeBox to patients who may have a concussion.
Eye-tracking concussion tool adopted by Minneapolis Clinic of Neurology Read More »
Please join us on August 10th at 12pm CT for a 30 minute webinar to learn about the HeadStrong Concussion Insurance program for high school students, a $0 deductible and no co-pay plan for students in AZ, CA (self-insured schools), MT, MI, MN, WY, WI, and IA, and the EyeBOX, the first and only FDA cleared objective concussion diagnostic device.
CEO Dr. Rosina Samadani joins webinar to discuss Headstrong Concussion Insurance Program Read More »
Watch Oculogica CEO, Dr. Rosina Samadani’s, and founder, Dr. Uzma Samadani’s discussion with the Talk Polymath podcast about the EyeBOX and how eye movement can be used to diagnose and treat concussions.
Rosina Samadani and Dr. Uzma Samadani discuss EyeBOX on Talk Polymath podcast Read More »
Oculogica CEO, Dr. Rosina Samadani, speaks with CEOX for their CEO Interview Series.
CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica Read More »
Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology
Oculogica new patient opens potential CTE test for live subjects Read More »
Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Oculogica adds patent for assessment of Impairment due to Cannabis Read More »
Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic
Oculogica receives DoD Grant for Development of Wearable concussion diagnostic Read More »
Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.
Australia Grant Approves First Objective Concussion Diagnostic tool Read More »
